152
|
Tyndall AV, Davenport MH, Wilson BJ, Burek GM, Arsenault-Lapierre G, Haley E, Eskes GA, Friedenreich CM, Hill MD, Hogan DB, Longman RS, Anderson TJ, Leigh R, Smith EE, Poulin MJ. The brain-in-motion study: effect of a 6-month aerobic exercise intervention on cerebrovascular regulation and cognitive function in older adults. BMC Geriatr 2013; 13:21. [PMID: 23448504 PMCID: PMC3598522 DOI: 10.1186/1471-2318-13-21] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2013] [Accepted: 02/21/2013] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Aging and physical inactivity are associated with declines in some cognitive domains and cerebrovascular function, as well as an elevated risk of cerebrovascular disease and other morbidities. With the increase in the number of sedentary older Canadians, promoting healthy brain aging is becoming an increasingly important population health issue. Emerging research suggests that higher levels of physical fitness at any age are associated with better cognitive functioning and this may be mediated, at least in part, by improvements in cerebrovascular reserve. We are currently conducting a study to determine: if a structured 6-month aerobic exercise program is associated with improvements or maintenance of both cerebrovascular function and cognitive abilities in older individuals; and, the extent to which any changes seen persist 6 months after the completion of the structured exercise program. METHODS/DESIGN Two hundred and fifty men and women aged 55-80 years are being enrolled into an 18-month combined quasi-experimental and prospective cohort study. Participants are eligible for enrollment into the study if they are inactive (i.e., not participating in regular physical activity), non-smokers, have a body mass index <35.0 kg/m(2), are free of significant cognitive impairment (defined as a Montreal Cognitive Assessment score of 24 or more), and do not have clinically significant cardiovascular, cerebrovascular disease, or chronic obstructive pulmonary airway disease. Repeated measurements are done during three sequential six-month phases: 1) pre-intervention; 2) aerobic exercise intervention; and 3) post-intervention. These outcomes include: cardiorespiratory fitness, resting cerebral blood flow, cerebrovascular reserve, and cognitive function. DISCUSSION This is the first study to our knowledge that will examine contemporaneously the effect of an exercise intervention on both cerebrovascular reserve and cognition in an older population. This study will further our understanding of whether cerebrovascular mechanisms might explain how exercise promotes healthy brain aging. In addition our study will address the potential of increasing physical activity to prevent age-associated cognitive decline.
Collapse
Affiliation(s)
- Amanda V Tyndall
- Department of Physiology & Pharmacology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
| | - Margie H Davenport
- Department of Physiology & Pharmacology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
| | - Ben J Wilson
- Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
| | - Grazyna M Burek
- Department of Physiology & Pharmacology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
| | - Genevieve Arsenault-Lapierre
- Department of Physiology & Pharmacology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
| | - Eryka Haley
- Department of Physiology & Pharmacology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
| | - Gail A Eskes
- Department of Physiology & Pharmacology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, B3H 2E2, Canada
- Department of Psychology, Faculty of Science, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada
- Department of Medicine (Neurology), Dalhousie University, Halifax, Nova Scotia, B3H 3A7, Canada
| | - Christine M Friedenreich
- Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, T2S 3C3, Canada
- Department of Oncology, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Department of Community Health Sciences, Faculty of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Faculty of Kinesiology, University of Calgary, Calgary, Alberta, T2N 1N4, Canada
| | - Michael D Hill
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Department of Community Health Sciences, Faculty of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Department of Radiology, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
| | - David B Hogan
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Department of Community Health Sciences, Faculty of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Brenda Stafford Foundation Chair in Geriatric Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
| | - R Stewart Longman
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Psychology Service, Alberta Health Services, Foothills Hospital, Calgary, Alberta, T2N 2T9, Canada
| | - Todd J Anderson
- University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Department of Cardiac Science, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
| | - Richard Leigh
- Department of Physiology & Pharmacology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Airway Inflammation Research Group, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Snyder Institute for Chronic Diseases, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
| | - Eric E Smith
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Department of Community Health Sciences, Faculty of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Department of Radiology, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
| | - Marc J Poulin
- Department of Physiology & Pharmacology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada
- Faculty of Kinesiology, University of Calgary, Calgary, Alberta, T2N 1N4, Canada
- University of Calgary, Calgary, Alberta, T2N 4N1, Canada
| |
Collapse
|
157
|
Latimer CS, Searcy JL, Bridges MT, Brewer LD, Popović J, Blalock EM, Landfield PW, Thibault O, Porter NM. Reversal of glial and neurovascular markers of unhealthy brain aging by exercise in middle-aged female mice. PLoS One 2011; 6:e26812. [PMID: 22046366 PMCID: PMC3201977 DOI: 10.1371/journal.pone.0026812] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2011] [Accepted: 10/04/2011] [Indexed: 01/14/2023] Open
Abstract
Healthy brain aging and cognitive function are promoted by exercise. The benefits of exercise are attributed to several mechanisms, many which highlight its neuroprotective role via actions that enhance neurogenesis, neuronal morphology and/or neurotrophin release. However, the brain is also composed of glial and vascular elements, and comparatively less is known regarding the effects of exercise on these components in the aging brain. Here, we show that aerobic exercise at mid-age decreased markers of unhealthy brain aging including astrocyte hypertrophy, a hallmark of brain aging. Middle-aged female mice were assigned to a sedentary group or provided a running wheel for six weeks. Exercise decreased hippocampal astrocyte and myelin markers of aging but increased VEGF, a marker of angiogenesis. Brain vascular casts revealed exercise-induced structural modifications associated with improved endothelial function in the periphery. Our results suggest that age-related astrocyte hypertrophy/reactivity and myelin dysregulation are aggravated by a sedentary lifestyle and accompanying reductions in vascular function. However, these effects appear reversible with exercise initiated at mid-age. As this period of the lifespan coincides with the appearance of multiple markers of brain aging, including initial signs of cognitive decline, it may represent a window of opportunity for intervention as the brain appears to still possess significant vascular plasticity. These results may also have particular implications for aging females who are more susceptible than males to certain risk factors which contribute to vascular aging.
Collapse
Affiliation(s)
- Caitlin S. Latimer
- Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
| | - James L. Searcy
- Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
| | - Michael T. Bridges
- Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
| | - Lawrence D. Brewer
- Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
| | - Jelena Popović
- Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
| | - Eric M. Blalock
- Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
| | - Philip W. Landfield
- Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
| | - Olivier Thibault
- Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
| | - Nada M. Porter
- Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
| |
Collapse
|